News
Archive
Novadip and Cliniques universitaires Saint-Luc report positive results for compassionate use of NVD003 on four pediatric patients
Novadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia
Resolve Therapeutics and Duke Medical School initiate observational study of cell-free RNA in polytrauma patients
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
VUV Analytics introduces HYDRA™: A breakthrough Vacuum Ultraviolet Detector for Liquid Chromatography
Novadip appoints Soumya Chandramouli as Chief Financial Officer
Back To News